tiprankstipranks

Jan Skvarka Insider Profile

4 Followers
Jan Skvarka, President & CEO, Director at Trillium Therapeutics, holds 0.00 shares in Trillium Therapeutics (Ticker: TRIL), holds 89.55K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE). Most recently, Jan Skvarka ― shares of Trillium Therapeutics on ― for an estimated value of ―.
tipranks
Jan Skvarka

Jan Skvarka
Trillium Therapeutics (TRIL)
President & CEO, Director

Not Ranked
Jan Skvarka has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$229K
100.00%
0.00%
A breakdown of Jan Skvarka's holdings

Insider Roles

Zentalis Pharmaceuticals
(ZNTL)
Director
Monte Rosa Therapeutics
(GLUE)
Director
Roles that Jan Skvarka holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Jan Skvarka

Jan Skvarka's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TRIL
Trillium Therapeutics
$0.00
Zentalis Pharmaceuticals
Jun 21, 2024
Director
Uninformative Buy
$229.25K
Monte Rosa Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Jan Skvarka's performance on stock

Jan Skvarka insider profile FAQ

What is the percentage of profitable transactions made by Jan Skvarka?
The percentage of profitable transactions made by Jan Skvarka is ―.
    What is the average return per transaction made by Jan Skvarka?
    The average return per transaction made by Jan Skvarka is ―.
      What stocks does Jan Skvarka hold?
      Jan Skvarka holds: TRIL, ZNTL, GLUE stocks.
        What was Jan Skvarka’s latest transaction?
        Jan Skvarka latest transaction was an Uninformative Buy of ―.
          What was Jan Skvarka's most profitable transaction?
          Jan Skvarka’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Jan Skvarka's role in Trillium Therapeutics?
            Jan Skvarka's role in Trillium Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.